First co-registered and co-aligned IVUS-OCT Platform for Intravascular Imaging - Company Positioned for U.S. Commercial Launch in a Growing ...

The TAG Award recognizes companies that are advancing innovation and driving meaningful progress within the healthcare sector. Conavi’s hybrid intravascular imaging platform represents a ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

TORONTO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi” or the “Company”), a medical device company focused on designing, manufacturing, and marketing ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

– Completed US$7.7 million financing and reverse takeover to take Company public – Chinese partner achieved regulatory approval, setting stage for royalty stream and triggering US$5.9 million payment, ...

TORONTO, April 02, 2026 (GLOBE NEWSWIRE)-- Conavi Medical Corp. (TSXV: CNVI; OTCQB: CNVIF) (“Conavi Medical” or the “Company”), a commercial stage medical device company focused on designing, ...

TORONTO--(BUSINESS WIRE)--Conavi Medical Inc. (www.conavi.com), a leader of hybrid imaging guidance for common minimally invasive heart procedures, has entered into agreements for over $20 million in ...

Next-Generation Novasight Hybrid™ System Submitted to U.S. FDA for 510(k) Clearance U.S. and European Class 1A Guidelines Reinforce Growing Adoption of Image-Guided PCI Peer-Reviewed Publications ...

TORONTO--(BUSINESS WIRE)--Conavi TM Medical Inc. (www.conavi.com) is pleased to announce the first clinical use of the Novasight TM Hybrid System, which enables ...